Recently, Zhang et al. found that DC vaccines expressing MUC1, MUC4, wilms tumor gene-1 (WT1), and KRAS antigens can enhance CTL response and prolong the median OS in PC patients (Zhang X. et al., 2023). This evidence concerns the gene KRAS and pachyonychia congenita.